Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001023175-11-000111
Filing Date
2011-03-11
Accepted
2011-03-11 14:21:52
Documents
4
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2010 ccap_201010kfinal.htm 10-K 328840
2 PRINCIPAL EXECUTIVE OFFICER CERTIFICATION f10dec10kex311.htm EX-31.1 6178
3 PRINCIPAL FINANCIAL OFFICER CERTIFICATION f10dec10kex312.htm EX-31.2 5963
4 SECTION 1350 CERTIFICATION f10dec10kex32.htm EX-32.1 2988
  Complete submission text file 0001023175-11-000111.txt   344982
Mailing Address 2157 S. LINCOLN 2157 S. LINCOLN SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN 2157 S. LINCOLN SALT LAKE CITY UT 84106 8013232395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

EIN.: 911803648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32363 | Film No.: 11681463
SIC: 6770 Blank Checks